ScienceScience Now

Avandia FDA review

Pharmaceutical IndustryFood and Drug AdministrationMedicineChemical IndustryDiabetes
After issuing safety warnings to diabetics taking the blockbuster drug Avandia, the FDA is defending research conducted by the company showing the drug to be safe. Some critics think the agency's review is a whitewash. Justin Sullivan
This photo is featured in these articles:
Loading